Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bader, Michael Prof. Dr. (1) Bähring, Sylvia Dr. (1) Bartolomaeus, Theda (1) Beule, Dieter Dr. (2) Blankenstein, Thomas Prof. Dr. (7) Borodina, Tatiana Dr. (1) Bunse, Mario Dr. (1) Daumke, Oliver Prof. Dr. (1) Del Giudice, Simone (1) Diecke, Sebastian Dr. (1) Di Virgilio, Michela Prof. Dr. (1) Forslund, Sofia Dr. (1) Gotthardt, Michael Prof. Dr. (1) Henssen, Anton Prof. Dr. med. (1) Heuser, Arnd Dr. (1) Hübner, Norbert Prof. Dr. (1) Izsvak, Zsuzsanna Dr. (1) Kammertöns, Thomas Dr. (2) Keller, Ulrich Dr. med. (3) Kempa, Stefan Dr. (1) Kirchner, Marieluise Dr. (1) Klußmann, Enno PD Dr. (1) Landthaler, Markus Prof. Dr. (3) Langanki, Reika (1) Liu, Tiannan (1) Lusatis, Simone (1) Marko, Lajos Dr. (1) Mastrobuoni, Guido Dr. (1) Mertins, Philipp Dr. (3) Minia, Igor Dr. (1) Müller, Dominik Prof. Dr. (1) Na, Il-Kang Dr. (1) Napieczynska, Hanna Dr. (1) Nazare, Marc (1) Ohler, Uwe Prof. Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Poncette, Lucia (1) Popova, Elena Dr. (1) Popp, Oliver Dr. (2) Prigione, Alessandro Prof. Dr. (1) Qadri, Fatimunnisa Dr. (1) Rahn, Hans-Peter Dr. (1) Rhein, Simone Dr. (1) Rosenberger, Leonie Milena (1) Schmitt, Clemens Prof. Dr. (1) Sholokh, Anastasiia (1) Simon, Katja Prof. Dr. (1) Singh, Manvendra Dr. (1) Sporbert, Anje Dr. (1) Spuler, Simone Prof. (1) Sunaga-Franze, Daniele Yumi Dr. (1) Taube, Martin (1) Uckert, Wolfgang Prof. Dr. (1) Villamil, Gabriel (1) Willimsky, Gerald Dr. (2) Wollert-Wulf, Brigitte (2) Wyler, Emanuel Dr. (1) Ziehm, Matthias Dr. (1) Zühlke, Kerstin Dr. (1) (-) Daniel, Peter Prof. Dr. (1) (-) Janz, Martin Dr. (8) (-) Leisegang, Matthias Prof. Dr. rer. nat. (2) (-) Mathas, Stephan Dr. (8) (-) Selbach, Matthias Prof. Dr. (12) Advanced Light Microscopy (1) Bioinformatik der Genregulation (1) (-) Biologie maligner Lymphome (12) Entwicklung Mechanismus-basierter Krebstherapien (2) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Genomdiversifikation & Integrität (1) Immundysregulationen in der Onkologie (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) Mobile DNA (1) (-) Molekulare Immunologie und Gentherapie (2) Myologie (1) (-) Proteom Dynamik (12) Proteomics (2) Proteomics and Metabolomics (1) RNA Biologie und Posttranscriptionale Regulation (3) Strukturbiologie Membran-assoziierter Prozesse (1) Translationale Kardiologie und Funktionelle Genomforschung (1) Translationale Onkologie solider Tumore (1) Tumorgenetik und zelluläre Stressantworten (1) Zellbiologie der Immunität (1) 1999 (4) 2000 (2) 2001 (4) 2002 (10) 2003 (4) 2004 (5) 2005 (8) (-) 2006 (8) 2007 (5) 2008 (7) 2009 (10) 2010 (7) 2011 (13) 2012 (6) 2013 (7) 2014 (14) 2015 (18) 2016 (12) 2017 (12) 2018 (8) 2019 (6) 2020 (13) 2021 (15) (-) 2022 (18) 2023 (14) 2024 (4) 26 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Leisegang, Matthias Prof. Dr. rer. nat.Mathas, Stephan Dr.Selbach, Matthias Prof. Dr.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie Proteom Dynamik20062022 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 16. März 2006 / Nature Robust Salmonella metabolism limits possibilities for new antimicrobials D. Becker M. Selbach C. Rollenhagen M. Ballmaier T.F. Meyer M. Mann D. Bumann 01. Dezember 2006 / Nat Methods Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK) M. Selbach M. Mann 01. Februar 2022 / Leukemia Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group C. Damaschin H. Goergen S. Kreissl A. Plütschow F. Breywisch S. Mathas J. Meissner M. Sökler M.S. Topp V. Vucinic A. Zimmermann B. von Tresckow M. Fuchs A. Engert P. Borchmann D.A. Eichenauer 01. Januar 2022 / Leuk Lymphoma Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals S. Denker A. Bittner M. Frick J. Kase J. Hoffmann C. Trenker U. Keller C. Bogner A. Hüttmann J. Dürig M. Janz S. Mathas R. Marks U. Krohn I.K. Na L. Bullinger C.A. Schmitt Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
16. März 2006 / Nature Robust Salmonella metabolism limits possibilities for new antimicrobials D. Becker M. Selbach C. Rollenhagen M. Ballmaier T.F. Meyer M. Mann D. Bumann
01. Dezember 2006 / Nat Methods Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK) M. Selbach M. Mann
01. Februar 2022 / Leukemia Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group C. Damaschin H. Goergen S. Kreissl A. Plütschow F. Breywisch S. Mathas J. Meissner M. Sökler M.S. Topp V. Vucinic A. Zimmermann B. von Tresckow M. Fuchs A. Engert P. Borchmann D.A. Eichenauer
01. Januar 2022 / Leuk Lymphoma Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals S. Denker A. Bittner M. Frick J. Kase J. Hoffmann C. Trenker U. Keller C. Bogner A. Hüttmann J. Dürig M. Janz S. Mathas R. Marks U. Krohn I.K. Na L. Bullinger C.A. Schmitt